Table 2 Relationships between clinicopathological factors and baseline NLR.
Characteristics | Baseline NLR | p value | |
|---|---|---|---|
<4 (n = 85) | ≥4 (n = 35) | ||
Age (years) | |||
<55 | 40 | 18 | 0.81 |
≥55 | 45 | 17 | |
Sex | |||
Female | 3 | 0 | 0.56 |
Male | 82 | 35 | |
Performance status | |||
0–1 | 77 | 28 | 0.20 |
≥2 | 8 | 7 | |
BMI | |||
<18.5 | 9 | 7 | 0.28 |
≥18.5 | 76 | 28 | |
Comorbidity score | |||
0–1 | 63 | 22 | 0.31 |
≥2 | 22 | 13 | |
Smoking (pack-years) | |||
<15 | 13 | 6 | 0.99 |
≥15 | 48 | 19 | |
Baseline Hb (g/dL) | |||
<11 | 4 | 7 | 0.02* |
≥11 | 81 | 28 | |
Tumour location | |||
Pyriform sinus | 69 | 28 | 0.97 |
Post-cricoid area | 4 | 2 | |
Posterior pharyngeal wall | 12 | 5 | |
Tumour differentiation | |||
Grade 1-2 | 47 | 26 | 0.42 |
Grade 3 | 14 | 4 | |
T classification | |||
T1-2 | 34 | 5 | 0.01* |
T3-4 | 51 | 30 | |
N classification | |||
N0 | 9 | 3 | 1.00 |
N1-3 | 76 | 32 | |
Stage | |||
I-II | 4 | 1 | 0.02* |
III | 13 | 2 | |
IVA | 59 | 22 | |
IVB | 9 | 10 | |